Based on amino acid sequence similarities that exist between the fibrinogen
gamma -chain and kappa -casein, and also functional similarities between m
ilk and blood coagulation, considerable effort has been made to investigate
the effects of milk proteins and peptides on platelet function and thrombo
sis. In particular, a number of peptides derived from the glycomacropeptide
segment of kappa -casein, have been shown to inhibit platelet aggregation
and thrombosis. KRDS, a peptide from lactoferrin has also been shown to inh
ibit platelet aggregation but to a lesser extent than its fibrinogen analog
ue RGDS. Despite their functional and structural similarities they do not a
ct in the same way on platelet function and are thought to affect thrombus
formation differently. Further investigation is needed to determine if thes
e milk-derived bioactive peptides are released naturally following ingestio
n and might therefore be useful as the basis for milk-based products with a
nti-thrombotic properties.